abstract |
This invention relates to pharmacologically-active novel ncompounds comprising β-fluoromethylene-5-hydroxytryptophan nand derivatives, to methods of inhibiting monoamine noxidase and to treating depression, and to pharmaceutical ncompositions containing the compounds. |